IHH seeks RM5.5bil from Japan’s Daiichi for Fortis deal


PETALING JAYA: IHH Healthcare Bhd says its unit is seeking compensation of up to 109.3 billion rupees (RM5.46bil) from Japan’s Daiichi Sankyo for its stake buy in India’s Fortis Healthcare.

In October 2023, Northern TK Venture (NTK), a subsidiary of IHH Healthcare, had filed a claim against the Japanese pharmaceuticals manufacturer saying it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018.

The company had initially claimed 20 billion yen (RM581.9mil) that Daiichi was ordered to pay as damages to NTK in November 2023.

After a report by an expert, NTK now claims compensation of between 4.24 billion rupees and 109.3 billion rupees.

IHH Healthcare, Asia’s largest healthcare group, had halted its open offer to buy an additional 26% stake in Fortis after Daiichi filed a contempt plea against Fortis founders, according to media reports.

Both Daiichi and Fortis did not immediately respond to a Reuters request for comment. — Reuters

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Wall St set for higher open as US-Iran ceasefire lifts sentiment
Golden Destinations’ IPO oversubscribed by 2.10 times
EPB proposes Main Market transfer
Infoline Tec subsidiary to purchase RM18.6mil factory buildings
PMW International ties up with STIDC for new Sarawak manufacturing facility
LSH unit secures Kuantan road upgrade contract
AIBIM: Islamic banking industry remains resilient amid Middle East uncertainties
Ringgit rises to 3.97 against US dollar at the close as US-Iran reaches ceasefire deal
Inta Bina bags RM32mil construction job
MNC Wireless to fund digital push with rights issue

Others Also Read